Canopy Growth Corp Net Cash Provided by (Used in) Investing Activities, Continuing Operations
Canopy Growth Corp (CGC) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -CAD 21.35 million for the 12-month period ending 2026-03-31, per its 10-K filed 2026-06-15.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2026-06-15
- Canopy Growth Corp net cash provided by (used in) investing activities, continuing operations for the quarter ending 2026-03-31 was -42.65M CAD.
- Canopy Growth Corp net cash provided by (used in) investing activities, continuing operations for the quarter ending 2025-12-31 was 5.27M CAD.
- Canopy Growth Corp net cash provided by (used in) investing activities, continuing operations for the quarter ending 2025-09-30 was 16.73M CAD.
- Canopy Growth Corp net cash provided by (used in) investing activities, continuing operations for the quarter ending 2025-06-30 was -705.00K CAD.
- Canopy Growth Corp net cash provided by (used in) investing activities, continuing operations for fiscal 2026 was -21.35M CAD.
- Canopy Growth Corp net cash provided by (used in) investing activities, continuing operations for fiscal 2025 was -61.91M CAD, a 128.19% decline from fiscal 2024.
- Canopy Growth Corp net cash provided by (used in) investing activities, continuing operations for fiscal 2024 was 219.60M CAD, a 51.99% decline from fiscal 2023.
- Canopy Growth Corp net cash provided by (used in) investing activities, continuing operations for fiscal 2023 was 457.43M CAD, a 98.16% increase from fiscal 2022.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2026-03-31 | -42.65M CAD derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-15 | -37.37M CAD derived: sum of 2 quarters · filed 2026-06-15 | -20.64M CAD derived: sum of 3 quarters · filed 2026-06-15 | -21.35M CAD 10-K · filed 2026-06-15 |
| 2025-12-31 | 5.27M CAD derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-06 | 22.00M CAD derived: sum of 2 quarters · filed 2026-02-06 | 21.30M CAD 10-Q · filed 2026-02-06 | 19.58M CAD derived: sum of 4 quarters · filed 2026-06-15 |
| 2025-09-30 | 16.73M CAD derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-07 | 16.02M CAD 10-Q · filed 2025-11-07 | 14.31M CAD derived: sum of 3 quarters · filed 2026-06-15 | -484.00K CAD derived: sum of 4 quarters · filed 2026-06-15 |
| 2025-06-30 | -705.00K CAD 10-Q · filed 2025-08-08 | -2.42M CAD derived: sum of 2 quarters · filed 2026-06-15 | -17.21M CAD derived: sum of 3 quarters · filed 2026-06-15 | -19.43M CAD derived: sum of 4 quarters · filed 2026-06-15 |
| 2025-03-31 | -1.71M CAD derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-15 | -16.51M CAD derived: sum of 2 quarters · filed 2026-06-15 | -18.73M CAD derived: sum of 3 quarters · filed 2026-06-15 | -61.91M CAD 10-K · filed 2026-06-15 |
| 2024-12-31 | -14.79M CAD derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-06 | -17.02M CAD derived: sum of 2 quarters · filed 2026-02-06 | -60.20M CAD 10-Q · filed 2026-02-06 | -45.31M CAD derived: sum of 4 quarters · filed 2026-06-15 |
| 2024-09-30 | -2.22M CAD derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-07 | -45.41M CAD 10-Q · filed 2025-11-07 | -30.52M CAD derived: sum of 3 quarters · filed 2026-06-15 | -45.65M CAD derived: sum of 4 quarters · filed 2026-06-15 |
| 2024-06-30 | -43.19M CAD 10-Q · filed 2025-08-08 | -28.29M CAD derived: sum of 2 quarters · filed 2026-06-15 | -43.43M CAD derived: sum of 3 quarters · filed 2026-06-15 | 34.03M CAD derived: sum of 4 quarters · filed 2026-06-15 |
| 2024-03-31 | 14.89M CAD derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-15 | -241.00K CAD derived: sum of 2 quarters · filed 2026-06-15 | 77.21M CAD derived: sum of 3 quarters · filed 2026-06-15 | 219.60M CAD 10-K · filed 2026-06-15 |
| 2023-12-31 | -15.13M CAD derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-07 | 62.32M CAD derived: sum of 2 quarters · filed 2025-02-07 | 204.71M CAD 10-Q · filed 2025-02-07 | 296.06M CAD derived: sum of 4 quarters · filed 2025-05-30 |
| 2023-09-30 | 77.45M CAD derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-08 | 219.84M CAD 10-Q · filed 2024-11-08 | 311.20M CAD derived: sum of 3 quarters · filed 2025-05-30 | 470.27M CAD derived: sum of 4 quarters · filed 2025-05-30 |
| 2023-06-30 | 142.38M CAD 10-Q · filed 2024-08-09 | 233.74M CAD derived: sum of 2 quarters · filed 2025-05-30 | 392.81M CAD derived: sum of 3 quarters · filed 2025-05-30 | |
| 2023-03-31 | 91.36M CAD derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-30 | 250.43M CAD derived: sum of 2 quarters · filed 2025-05-30 | 457.43M CAD 10-K · filed 2025-05-30 | |
| 2022-12-31 | 159.07M CAD derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-09 | 366.07M CAD 10-Q · filed 2024-02-09 | ||
| 2022-09-30 | 207.00M CAD 10-Q · filed 2023-11-09 | |||
| 2022-03-31 | 230.84M CAD 10-K · filed 2024-05-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |